Related Experiment Video
Updated: Apr 27, 2026
09:27
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
10.6K
Developments in HIV-1 immunotherapy and therapeutic vaccination
Peter Lawrence Smith1, Helen Tanner1, Angus Dalgleish1
1St George's, University of London, Institute for Infection and Immunity 1 Cranmer Terrace, London SW17 0RE UK.
F1000Prime Reports
|July 4, 2014
Summary
New HIV-1 therapies, including immunotherapy and therapeutic vaccines, are crucial for better infection control and potentially a functional cure. These advancements aim to improve treatment outcomes beyond current antiretroviral therapy (ART).
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- The human immunodeficiency virus (HIV-1) pandemic necessitates novel therapeutic strategies beyond prophylactic vaccines and antiretroviral therapy (ART).
- ART has limitations including access, compliance, toxicity, non-AIDS comorbidities, and incomplete immune reconstitution, highlighting the need for additional interventions.
- Existing prophylactic vaccines have shown limited success, underscoring the need for therapeutic approaches.
Purpose of the Study:
- To review the latest developments in immunotherapy and therapeutic vaccination for HIV-1.
- To explore the potential of these novel strategies in controlling HIV-1 infection, enabling treatment interruptions, and achieving a functional cure.
- To discuss the evolving landscape of HIV-1 treatment in the context of ART.
Main Methods:
- Literature review of recent advancements in HIV-1 immunotherapy and therapeutic vaccination.
- Analysis of current challenges and future directions in HIV-1 treatment.
- Synthesis of findings on the potential impact of immunotherapy and therapeutic vaccination.
Main Results:
- Few prophylactic HIV-1 vaccines have advanced to late-stage trials, with limited efficacy demonstrated.
- Antiretroviral therapy (ART) has improved HIV-1 management but presents challenges like adherence, toxicity, and non-AIDS related morbidities.
- Immunotherapy and therapeutic vaccination show promise as complementary or alternative strategies to ART.
Conclusions:
- Immunotherapy and therapeutic vaccination represent promising avenues for improved HIV-1 control and the pursuit of a functional cure.
- These approaches may allow for structured treatment interruptions and better management of HIV-1 infection.
- Continued research and development in immunotherapy and therapeutic vaccination are essential for advancing HIV-1 treatment paradigms.
Related Concept Videos
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:29Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
01:51Vaccinations
43.9K
Overview
43.9K
01:10Retrovirus Life Cycles
42.9K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
42.9K
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K